These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1820880)

  • 21. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
    Srinivas NR; Shyu WC; Gleason C; Schuster A; Greene DS; Barbhaiya RH
    Clin Pharmacol Ther; 1997 Oct; 62(4):408-16. PubMed ID: 9357392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-dose pharmacokinetics of nizatidine (Axid) in children.
    Abdel-Rahman SM; Johnson FK; Manowitz N; Holmes GB; Kearns GL
    J Clin Pharmacol; 2002 Oct; 42(10):1089-96. PubMed ID: 12362922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteers.
    Itokazu GS; Fischer JH; Manitpisitkul P; Hariharan R; Danziger LH
    Pharmacotherapy; 2002 Nov; 22(11):1420-5. PubMed ID: 12432968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative pharmacokinetics of acemetacin in young subjects and elderly patients.
    Jones RW; Collins AJ; Notarianni LJ; Sedman E
    Br J Clin Pharmacol; 1991 May; 31(5):543-5. PubMed ID: 1888622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nizatidine, and H2-receptor antagonist: disposition and safety in the elderly.
    Callaghan JT; Rubin A; Knadler MP; Bergstrom RF
    J Clin Pharmacol; 1987 Aug; 27(8):618-24. PubMed ID: 2888796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of nizatidine in dogs and rats.
    Sano H; Sato H; Furuta S; Mogi M; Matsuki Y
    Xenobiotica; 1991 Oct; 21(10):1257-64. PubMed ID: 1796603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of a sustained-release product of indomethacin in the elderly.
    Bruguerolle B; Barbeau G; Bélanger PM; Labrecque G
    Gerontology; 1986; 32(5):277-85. PubMed ID: 3569930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal variation in the pharmacokinetics of nizatidine in healthy volunteers and in patients with peptic ulcer disease.
    Jamali F; Thomson AB; Kirdeikis P; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
    J Clin Pharmacol; 1995 Nov; 35(11):1071-5. PubMed ID: 8626880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers.
    Borin MT; Peters GR; Smith TC
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1944-8. PubMed ID: 2291659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of molsidomine and of its active metabolite, SIN-1 (or linsidomine), in the elderly.
    Spreux-Varoquaux O; Ulmer B; Cordonnier P; Forestier A; Pays M; Ducreuzet C; Advenier C
    Fundam Clin Pharmacol; 1991; 5(6):549-56. PubMed ID: 1955198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women.
    Friedman H; Greenblatt DJ; Scavone JM; Burstein ES; Ochs HR; Harmatz JS; Shader RI
    Clin Pharmacokinet; 1989 May; 16(5):312-6. PubMed ID: 2743704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of pentopril in the elderly.
    Rakhit A; Kochak GM; Tipnis V; Radensky P; Hurley ME; Williams R
    Br J Clin Pharmacol; 1987 Sep; 24(3):351-7. PubMed ID: 2822067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects.
    Molinaro M; Villani P; Regazzi MB; Rondanelli R; Doveri G
    Eur J Clin Pharmacol; 1992; 43(1):105-7. PubMed ID: 1505603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of zileuton in healthy young and elderly volunteers.
    Braeckman RA; Granneman GR; Locke CS; Machinist JM; Cavannaugh JH; Awni WM
    Clin Pharmacokinet; 1995; 29 Suppl 2():42-8. PubMed ID: 8620670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of age and gender on pharmacokinetics of cefepime.
    Barbhaiya RH; Knupp CA; Pittman KA
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1181-5. PubMed ID: 1416818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients.
    Taylor IW; Chasseaud LF; Taylor T; James I; Dorf G; Darragh A
    Br J Clin Pharmacol; 1991 Aug; 32(2):242-5. PubMed ID: 1931475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etodolac kinetics in the elderly.
    Scatina J; Hicks D; Kraml M; Weidler D; Garg D; Sanda M
    Clin Pharmacol Ther; 1986 May; 39(5):550-3. PubMed ID: 2938866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage.
    Flanagan RJ; Johnston A; White AS; Crome P
    Br J Clin Pharmacol; 1989 Oct; 28(4):463-9. PubMed ID: 2590604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g.
    Nilsen OG; Rennemo F; Rennemo R; Lenfant B
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():71-5. PubMed ID: 2074254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of mianserin.
    Shami M; Elliott HL; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):313S-322S. PubMed ID: 6824562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.